October 2024
The automatic coagulation system market was estimated at US$ 2.41 billion in 2023 and is projected to grow to US$ 4.79 billion by 2034, rising at a compound annual growth rate (CAGR) of 6.44% from 2024 to 2034. The increasing incidences of chronic disorders, technological advancements, and growing research and development drive the market.
Unlock Infinite Advantages: Subscribe to Annual Membership
Automatic coagulation systems are equipment used to measure the levels of blood coagulation factors. They are either semi- or fully-automatic multi-parameter hemostasis analyzers used to perform coagulation tests, and chromogenic and immunologic assays. Various parameters such as fibrinogen levels, platelet count, clot retraction, clotting time, prothrombin time, thrombin time, etc. can be measured using automated coagulation systems. There may be different types of coagulation systems: benchtop analyzers, required to be placed on a laboratory bench, and portable analyzers, for carrying out tests at the bedside.
The rising incidences of hematological disorders like hemophilia, liver disease, and nutrient malabsorption promote the use of automatic coagulation systems. They are also used to monitor patients who are at high risk of bleeding before and after surgery. The increasing demand for point-of-care (PoC) diagnostics and growing research and development augment market growth.
An automated coagulation system does not require any skilled professional during the analysis or working of the instrument. Advanced research has an inclination towards point-of-care (PoC) testing, primarily focused on improved systems miniaturization and functional integration. The demand for PoC coagulation technologies increases due to central laboratories’ inability to deliver data quickly enough to enable anticoagulant medication to be started and administered on time.
PoC testing involves analyzing blood coagulation at the patient’s bedside, i.e. in the emergency department, operating rooms, clinics, and ICUs. The three different methods for PoC include simple anticoagulation monitoring devices, PoC coagulation tests available to assess primary hemostasis and platelet function, and viscoelastic coagulation monitoring devices. Hence, PoC coagulation testing is faster and more comprehensive than traditional laboratory tests and enables effective and economical management.
The major challenge of the market is the high cost of the equipment, resulting in less affordability for several small and medium enterprises. The cost of an automated coagulation system usually ranges from a thousand euros to several tens of thousands of euros. Apart from the equipment, the cost of reagents, maintenance, and other supplies contribute to overall expense, limiting adoption. Another major challenge of the market is the increased risk of downtime. Lack of regular calibration and maintenance leads to critical system failures and inaccurate results, impacting workflow efficiency.
North America held the largest share of the automatic coagulation system market in 2023. The presence of key players, increasing investments & collaborations, advanced healthcare infrastructure, rising incidences of hematological disorders, and favorable government policies drive the market. The automated coagulation systems are regulated by government agencies like the US Food and Drug Administration and Health Canada. The presence of key players in the US constitutes a major share of the market.
The increasing incidences of hemophilia and other hematological disorders potentiate the demand for automatic coagulation systems for early diagnosis. According to the Centers for Disease Control and Prevention, around 33,000 males in the US are estimated to be living with hemophilia. While in Canada, about 3,900 people are affected by hemophilia A, and 800 people are affected by hemophilia B.
Asia-Pacific is expected to grow at the fastest rate in the automatic coagulation system market during the forecast period. The rising incidences of blood disorders, increasing number of surgeries, growing research and development, and increasing demand for PoC testing drive the market. Patients with a high risk of bleeding are assessed before and after surgery. Hence, the increasing number of surgeries in the region increases the demand for automatic coagulation systems.
In 2023, around 1,735 surgeries per 100,000 population underwent surgery in Hong Kong, China. In 2022, Korea reported around 3,235 surgeries per 100,000 population surgeries. In India, it is estimated that approximately 30 million surgeries are performed annually. Additionally, the surge in COVID-19 cases in the region increases the demand for coagulation parameters like D-dimer and prothrombin time. Furthermore, the growing healthcare and biotech sector and rising adoption of advanced diagnostics boost the market.
By type, the fully automatic segment is anticipated to gain traction in the automatic coagulation system market in the upcoming years. A fully automated coagulation system operates autonomously without requiring a trained professional. Hence, organizations with a lack of skilled personnel can incorporate an automated system. It offers numerous benefits including reducing the risks of manual errors, streamlining lab operations, enhancing workflow, and minimizing turnaround time.
By application, the hospital segment dominated the automatic coagulation system market in 2023. The segmental growth is attributed to the increasing number of patients in hospitals, the increasing number of surgeries, and favorable infrastructure. In addition, the growing demand for PoC coagulation testing potentiates the segment’s growth.
The biotechnology company segment is predicted to grow with the highest CAGR in the automatic coagulation system market during the studied years. The growing biotech R&D activities and increasing investments favor the segment’s growth. An automated coagulation system aids in effective hemostasis testing and diagnosing causes of hemorrhages, potentiating the development of novel anti-coagulant therapies.
By Type
By Application
By Region
October 2024
October 2024
September 2024
September 2024
Deepa has certified the degree of Master’s in Pharmacy in the Pharmaceutical Quality Assurance department from Dr D.Y. Patil College of Pharmacy. Her research is focused on the healthcare industry. She is the author or co-author of four Review Articles, which include Solid dispersion a strategic method for poorly soluble drugs and solubility improvement techniques for poorly soluble drugs, Herbal Drugs Used In Treatment Of Cataracts, Nano sponges And Their Application in Cancer Prevention and Ayurvedic Remedies of Peptic ulcer. She has also published a Research Article on the Formulation and Evaluation of Mucoadhesive Tablets of Miconazole cocrystal which was published in GIS Science Journal Volume 9 Issue 8. Her passion for secondary research and desire to take on the challenge of solving unresolved issues is making her flourish is the in the research sector.
Annual Access, Limitless Research! Unlock all market research reports with our annual subscription. Stay on top of market trends and crucial insights year-round!
2500+
Client Queries in 20235000+
Insights Published60+
Consulting Projects Per Year40+
Analysts